Staburo participated in the APF meeting on 24 November 2017 in Freiburg. This year, the APF was hosted by Roche. Speakers from pharmaceutical industry, academia and regulatory agencies discussed important topics on estimands, safety and Health Technlogy Assessment.
The APF (Arbeitsgruppe Pharmazeutische Forschung) is a German pharmaceutical research working group for statisticians in the pharmaceutical and healthcare industry, academia and regulatory agencies. The APF is part of the International Biometric Society.
We also attended the get-together on 23 November 2017 at the restaurant Großer Meyerhof. It was a great opportunity to meet other statisticians.
The 2nd Annual Biosimilars Forum was hosted in Budapest in October 2017. Clinicians, statisticians and regulatory representatives from around the world gathered here, to share with each other their perspectives on this hot topic of research, in lectures and informal discussions. The professional lectures of the event reflected the challenges in this special and complex field of drug development.
Use Staburo’s expertise with biosimilars
Staburo is already supporting several biosimilars companies in the development of their biosimilar drugs. We are involved in the stability and similarity testing at an analytical level, according to the latest draft FDA guidelines and EMA reflection paper. Besides this, we bring our statistical knowledge into the companies for innovative study designs and plan state-of-the-art statistical analyses that are key for bringing biosimilars to the market as fast as possible.
Staburo took part in the WiMa17 Congress at the University Ulm. The WiMa Congress is a networking forum for companies and students from a mathematics, finance, IT, and biometry background.
At the WiMa Congress, companies have the opportunity to present themselves, get in contact with their possible future employees and have personal interview sessions with them. Furthermore, there are different presentations on very interesting topics, during the entire day. Staburo provided insights into crossover correction methods in oncology, as well as an overview on other offered services and the work of biostatisticians and statistical programmers in clinical research. A current employee, who studied medical biometry at Ulm University also shared a short personal testimonial about her start at Staburo.
A big thank you for inviting us and for the great organisation of this event. We will definitely come back next year!